Document Detail

Chromatin changes in papillary thyroid carcinomas may predict patient outcome.
MedLine Citation:
PMID:  23212308     Owner:  NLM     Status:  Publisher    
PURPOSE: New insights in prognostic predictions are urgently needed for papillary thyroid carcinoma (PTC). The present study aimed to investigate whether computerized analysis of chromatin texture allows the identification of PTC patients with a poor prognosis. METHODS: We randomnly selected paraffin-embedded blocks from surgical specimens of 103 classic cases of PTC. During follow-up, 68 of the patients were classified as free of disease, whereas 35 presented with recurrences. Characteristics of chromatin were obtained from digitized images of at least 100 randomly selected tumor nuclei per patient. An independent series of 30 goiters was used to validate our observations. RESULTS: Stage, age and distant metastases were found to serve as independent prognostic factors for survival. In addition, multivariate Cox regression confirmed variable cluster prominence as an independent prognostic factor. By comparing malignant and benign nodules, we found that the PTC lesions presented with higher nuclear perimeters, nuclear areas, Minkowski fractal dimensions, optical densities and nuclear longest chords. CONCLUSION: From our results we conclude that, in conjunction with clinical and histopathological data, morphometric data may provide relevant prognostic information in PTC patients.
R C Ferreira; L L Cunha; P S Matos; R L Adam; F Soares; J Vassallo; L S Ward
Related Documents :
3804038 - Combination cyclophosphamide, adriamycin, and cis-platinum in recurrent and metastatic ...
11862438 - Intracystic chemotherapy with bleomycin in the treatment of craniopharyngiomas.
21626328 - Combined lysosomal protein transmembrane 4 beta-35 and argininosuccinate synthetase exp...
22968238 - Synchronous pulmonary metastases from renal cell carcinoma--a whole nation study on pre...
9893628 - Efficacy and toxicity of 2-chlorodeoxyadenosine (cladribine)--2 h infusion for 5 days--...
12196368 - Irinotecan and raltitrexed: an active combination in advanced colorectal cancer.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-5
Journal Detail:
Title:  Cellular oncology (Dordrecht)     Volume:  -     ISSN:  2211-3436     ISO Abbreviation:  Cell Oncol (Dordr)     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101552938     Medline TA:  Cell Oncol (Dordr)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Laboratory of Cancer Molecular Genetics, Faculty of Medical Sciences, University of Campinas (FCM- Unicamp), Rua Tessália Vieira de Camargo 126 - Barão Geraldo, 13083-970, Campinas, São Paulo, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A novel antitubulin agent, DPQZ, induces cell apoptosis in human oral cancer cells through Ras/Raf i...
Next Document:  The dual role of paramagnetic particles for integrated lysis and measurement in a rapid immunoassay ...